Corporate Profile

Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company's mission is to advance the care of patients suffering from life-threatening diseases worldwide. Gilead has operations in more than 30 countries worldwide, with headquarters in Foster City, California.

Recent Press Releases

February 28, 2017 - 5:01 p.m.
Gilead Sciences to Present at the Barclays Global Healthcare Conference on Tuesday, March 14Printer Friendly Version 
February 14, 2017 - 7:01 p.m.
Gilead Announces 144-Week Data Evaluating Safety and Efficacy of Genvoya® for Treatment of HIV-1 in Treatment-Naïve AdultsPrinter Friendly Version 

Upcoming Events

Wednesday, April 19, 2017 through Sunday, April 23, 2017
The International Liver Congress 2017: European Association for the Study of the Liver (EASL)
LocationAmsterdam, The Netherlands

Most Viewed Links

Updated 03/24/17
1.SEC Filings
3.Annual Reports
4.Stock Information
5.Fundamentals - Snapshot
* Data collected 03/16/17 - 03/23/17

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.
NASDAQ (US Dollar)
 Stock is Down 0.34 (0.50%)
Data as of 03/23/17 4:00 p.m. ET
Minimum 20 minute delay
Refresh Quote
Recent Webcasts
Gilead Sciences at RBC Capital Markets 2017 Global Healthcare Conference

February 22, 2017 9:30 a.m. ET
Fourth Quarter 2016 Gilead Sciences Earnings Conference Call

February 07, 2017 4:30 p.m. ET